Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03393494 · ClinicalTrials.gov registry record · Phase 3
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face
A Phase 3 study, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 825
- Enrollment target
NCT03393494: Completed Phase 3 study, sponsored by Padagis.
NCT03393494 is a Phase 3 study that has completed, run by Padagis. The registered enrollment target is 825 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03393494, a Phase 3 study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 825 participants
- Enrollment target
Study Summary
To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris
Interventions
- DRUG Placebo
- DRUG Adapalene and Benzoyl Peroxide Topical Gel
- DRUG Epiduo Topical Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2019-01-05 |
| Phase | Phase 3 |
What the finished NCT03393494 record still lists
NCT03393494 is an interventional study that assigns participants to a tested intervention. The registered 825 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03393494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03393494 about?
NCT03393494 is a clinical study titled "Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face". To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris
What is the current status of trial NCT03393494?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 825 participants. The study started on 2017-12-13. Estimated completion is 2019-01-05.
What interventions are being tested in trial NCT03393494?
The interventions under investigation include: Placebo (DRUG), Adapalene and Benzoyl Peroxide Topical Gel (DRUG), Epiduo Topical Product (DRUG).
Who is sponsoring clinical trial NCT03393494?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03393494's enrollment target sits among peer trials
825 400th of 2000 higher than 1,599 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
- NCT07318077 · 825 participants · NA
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI